20 years of revenue, earnings, cash-flow and balance-sheet history from public filings.
Structure Therapeutics Inc. - American Depositary Shares (GPCR) operates in the NASDAQ industry and is headquartered in South San Francisco, United States with about 281 employees. Its market capitalization is roughly $1 billion. In the fiscal year ended 2025-12-31, GPCR reported $0M in revenue and ($141M) in net income.
Structure Therapeutics Inc., a clinical stage global biopharmaceutical company, develops and delivers novel oral small molecule therapeutics to treat various chronic diseases with unmet medical needs in the United States.
Interactive charts & full statements →
| Income statement | TTM → 2026-06-30 | 2025-12-31 | 2024-12-31 | 2023-12-31 | 2022-12-31 | 2021-12-31 | 2020-12-31 |
|---|---|---|---|---|---|---|---|
| Total Revenue | $0M | $0M | $0M | $0M | $0M | $0M | $0M |
| Gross Profit | — | ($4M) | ($3M) | ($1M) | ($1M) | $0M | $0M |
| Gross Margin % | — | — | — | — | — | — | — |
| Operating Income (EBIT) | ($258M) | ($288M) | ($158M) | ($103M) | ($53M) | ($38M) | $0M |
| Operating Margin % | — | — | — | — | — | — | — |
| Net Income | ($215M) | ($141M) | ($123M) | ($90M) | ($51M) | ($40M) | $0M |
| Net Margin % | — | — | — | — | — | — | — |
| EBITDA | ($212M) | ($139M) | ($121M) | ($76M) | ($52M) | ($38M) | $0M |
| Earnings Per Share (EPS) | $-3.08 | $-2.39 | $-2.33 | $-2.44 | $-1.40 | $-1.09 | $-0.00 |
| Shares Outstanding (M) | 73M | 59M | 53M | 37M | 37M | 37M | 37M |
USD; $M / $B as marked. Newest period first. Source: public company filings (via Yahoo Finance aggregation).
| Quarterly income statement | 2026-06-30 | 2026-03-31 | 2025-12-31 | 2025-09-30 | 2025-06-30 | 2025-03-31 | 2024-12-31 | 2024-09-30 |
|---|---|---|---|---|---|---|---|---|
| Total Revenue | $0M | $0M | $0M | $0M | $0M | $0M | $2M | $0M |
| Gross Profit | — | ($1M) | — | — | ($1M) | ($1M) | $1M | $0M |
| Gross Margin % | — | — | — | — | — | — | 50.0% | — |
| Operating Income (EBIT) | ($119M) | ($90M) | $24M | ($74M) | ($70M) | ($56M) | ($47M) | ($46M) |
| Operating Margin % | — | — | — | — | — | — | -2641.9% | — |
| Net Income | ($106M) | ($76M) | $33M | ($66M) | ($62M) | ($47M) | ($36M) | ($34M) |
| Net Margin % | — | — | — | — | — | — | -2047.9% | — |
| EBITDA | ($105M) | ($75M) | $34M | ($65M) | ($61M) | ($46M) | ($36M) | ($34M) |
| Earnings Per Share (EPS) | $-1.46 | $-1.05 | $0.56 | $-1.12 | $-1.06 | $-0.82 | $-0.64 | $-0.59 |
| Shares Outstanding (M) | 73M | 72M | 59M | 58M | 58M | 57M | 57M | 57M |
USD; $M / $B as marked. Newest period first. Source: public company filings (via Yahoo Finance aggregation).
| Cash flow | TTM → 2026-06-30 | 2025-12-31 | 2024-12-31 | 2023-12-31 | 2022-12-31 | 2021-12-31 | 2020-12-31 |
|---|---|---|---|---|---|---|---|
| Cash from Operations (CFO) | ($220M) | ($222M) | ($117M) | ($79M) | ($46M) | ($32M) | ($14M) |
| Capital Expenditures (CapEx) | $4M | $4M | $1M | $2M | $0M | $1M | $0M |
| Free Cash Flow (FCF) | ($225M) | ($226M) | ($118M) | ($82M) | ($46M) | ($33M) | ($14M) |
| FCF Margin % | — | — | — | — | — | — | — |
USD; $M / $B as marked. Newest period first. Source: public company filings (via Yahoo Finance aggregation).
| Quarterly cash flow | 2026-06-30 | 2026-03-31 | 2025-12-31 | 2025-09-30 | 2025-06-30 | 2025-03-31 | 2024-12-31 | 2024-09-30 |
|---|---|---|---|---|---|---|---|---|
| Cash from Operations (CFO) | ($120M) | $15M | ($64M) | ($51M) | ($55M) | ($52M) | ($36M) | ($20M) |
| Capital Expenditures (CapEx) | $0M | $1M | $1M | $2M | $0M | $0M | $0M | $1M |
| Free Cash Flow (FCF) | ($120M) | $14M | ($66M) | ($53M) | ($55M) | ($53M) | ($36M) | ($20M) |
| FCF Margin % | — | — | — | — | — | — | -2048.1% | — |
USD; $M / $B as marked. Newest period first. Source: public company filings (via Yahoo Finance aggregation).
| Balance sheet | 2026-06-30 | 2025-12-31 | 2024-12-31 | 2023-12-31 | 2022-12-31 | 2021-12-31 | 2020-12-31 |
|---|---|---|---|---|---|---|---|
| Total Assets | $1.4B | $1.6B | $903M | $482M | $98M | $111M | $39M |
| Cash & Cash Equivalents | $273M | $800M | $170M | $130M | $26M | $105M | $16M |
| Total Liabilities | $71M | $68M | $38M | $29M | $213M | $176M | $61M |
| Total Debt (Short + Long-Term) | $3M | $3M | $2M | $1M | $0M | $0M | $0M |
| Total Shareholders' Equity | $1.4B | $1.5B | $865M | $453M | ($115M) | ($65M) | ($22M) |
USD; $M / $B as marked. Newest period first. Source: public company filings (via Yahoo Finance aggregation).
Quarterly statements, profitability ratios, price history, insider activity and institutional holders are in the interactive GPCR viewer.
About TickerBase · Data methodology & sources · Privacy · Terms